Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026
Same author

Linking access to stewardship: a pathway for introducing reserve antibiotics in India.

JAC-antimicrobial resistance·2026
Same author

Effectiveness of serial C-reactive protein point-of-care testing in optimizing antibiotic treatment in neonates and children in Zanzibar: an open-label, individual randomized controlled clinical trial protocol.

BMC pediatrics·2026
Same author

Editorial: Advances in stem cell engineering: paving the way for regenerative medicine.

Frontiers in bioengineering and biotechnology·2026
Same author

Palladium-Catalyzed Site-Selective Nitration of 1-Aryl-1<i>H</i>-indazole: A Direct Access to 1-(2-Nitroaryl)-1<i>H</i>-indazoles.

The Journal of organic chemistry·2026
Same author

Enhancing memory T cell responses through Soluble Leishmania antigen and natural adjuvants against Leishmania donovani in murine model.

Microbial pathogenesis·2026

Related Experiment Video

Updated: May 5, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

16.0K

Leishmania vaccine development: A comprehensive review.

Isha Saini1, Jyoti Joshi2, Sukhbir Kaur1

  • 1Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, India.

Cellular Immunology
|April 26, 2024
PubMed
Summary

Developing effective leishmaniasis vaccines is crucial due to drug limitations. Research focuses on antigen-based vaccines and promising candidates, aiming for accessible control tools.

Keywords:
AntigenImmune responseLeishmaniasisParasitic infectionVaccine

More Related Videos

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

8.2K
Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

781

Related Experiment Videos

Last Updated: May 5, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

16.0K
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

8.2K
Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

781

Area of Science:

  • Tropical medicine
  • Parasitology
  • Vaccinology

Background:

  • Leishmaniasis poses a significant global health burden, categorized as a WHO Category I disease due to its complexity.
  • Traditional treatments for leishmaniasis are costly, exhibit resistance, and have toxic side effects, necessitating alternative therapies.
  • Natural infection with Leishmania induces strong immunity, driving vaccine development efforts.

Purpose of the Study:

  • To review recent advancements in leishmaniasis vaccine development.
  • To highlight the challenges in creating and implementing effective leishmaniasis vaccines.

Main Methods:

  • Review of current vaccine strategies, including those using parasite antigen epitopes (Leish-F1, F2, F3).
  • Examination of approaches combining parasite antigens or insect vector salivary gland extracts, with or without adjuvants.
  • Analysis of promising preclinical vaccine candidates with supporting animal data.

Main Results:

  • Several vaccine candidates, including Lmcen-/- and LmexCen-/-, show promise in animal models.
  • Some leishmaniasis vaccine candidates have entered or are progressing towards clinical trials.
  • Ongoing research explores diverse antigen sources and formulations for enhanced vaccine efficacy.

Conclusions:

  • Translating leishmaniasis research into affordable and accessible vaccines remains a critical challenge.
  • Overcoming implementation hurdles is essential for refining outcomes for individuals susceptible to leishmaniasis.
  • Continued research and development are vital for effective leishmaniasis control.